“a process for extraction of a cycloartane triterpenoid”
Patent Information
- Application Number
- IN202511040957
- Authority / Receiving Office
- IN · IN
- Patent Type
- Patents
- Current Assignee / Owner
- Filing Date
- 2025-04-28
- Publication Date
- 2026-07-10
- Estimated Expiration
- 2045-04-28
AI Technical Summary
Current extraction methods for phytoconstituents in cancer treatment, such as those using natural deep eutectic solvents (NADES), are cumbersome, expensive, and time-consuming, often involving complex constituents and techniques that alter optimization results, pose ecological risks, and are not cost-effective or sustainable.
A solvent extraction process using a combination of ethanol and a natural deep eutectic solvent (NADES) comprising acetic acid and mannitol/hexanoic acid is employed to extract cycloartane triterpenoids, particularly beddomeilactone, from Dysoxylum malabaricum bark, involving steps like grinding, filtration, ultrasonication, and vacuum concentration to achieve high purity and yield.
The process achieves a cost-effective, eco-friendly extraction of beddomeilactone with 80% purity, demonstrating significant cytotoxicity against various breast cancer cells, offering a sustainable and efficient management of breast cancer.
Abstract
Description
FIELD OF THE INVENTIONThe present invention relates to the field of phytochemical extraction. Moreparticularly, the present invention relates to a process for extraction of acycloartane triterpenoid from the bark of Dysoxylum malabaricum throughsolvent extraction method for effective management of breast cancer.BACKGROUND OF THE INVENTIONCancer is a disease that may randomly initiate in any organ or tissue of thebody and spreads to adjoining parts or organs of the body. Ductal carcinoma,commonly known as breast cancer, is the second leading cause of deathglobally, with an estimated account of 10.6 million deaths every year. Thecontinuous growth of breast cancer tremendously exerts physical, emotionaland financial strain on individuals, families, communities and health systems.In accordance with estimated death rates every year, treatment of cancer hasbeen a constant struggle with relatively less success. However, many differenttechniques for the treatment of cancer have been developed for themanagement of cancer, especially breast cancer.The currently available techniques for the treatment of breast cancer includesurgical removal and radiation-based treatment. Further, the radiation-basedtreatment for breast cancer includes chemotherapy. However, in case ofchemotherapy, the chances of recurrence of cancer, drug resistance and toxiceffects on non-targeted tissues thereby significantly impairing the quality oflife of the cancer patient, are possible and are the major issues in following thecourse of treatment through chemotherapy. Therefore, in order to combatsuch issues, researches have conducted experiments, both in vitro and in vivofor the management of cancer, whereby the cancer cell lines plays a verycrucial role in in vitro model systems that are utilized on a large. Further, themanagement of cancer may also be done through certain natural sources,since, the natural sources possess highly active phytoconstituents that activelydamage the cancer cells. However, extraction of such phytoconstituents is amatter of concern.EP3485874A1 relates to a method of preparing or optimizing a systemcomprising a natural deep eutectic solvent (NADES) and active ingredients.Preferably, such systems include a polymeric precipitation inhibitor (PPI).Further, the invention relates to formulations comprising or consisting of suchdeveloped NADES based systems. However, the cited document disclosesabout a method that is mostly inhibited by molecular interaction between PPIand drug, due to ionic interactions, which makes the extraction ofphytoconstituents a cumbersome process.WO2016162703A1 discloses about eutectic extraction solvent for extractingplant (e.g. vegetable) and / or animal and / or prokaryotic biological material,wherein the solvent is a clear, stable and fluid mixture comprising: (a) betaineor a hydrated form of betaine; (b) at least one hydrogen bond donorcompound selected from the group consisting of polyols and organic acids;and (c) water with the proviso that the eutectic extraction solvent does notcontain any exogenous sugar and / or amine salt and / or anion. However, thecited document discloses a method that uses complex constituents whichmakes the production process time-consuming and expensive.Taofiq Oludemi et al., The Royal Society of Chemistry 2018, Food Funct.,2018, 9, 209-226 discloses about the extraction of triterpenoids and phenoliccompounds from Ganoderma lucidum by using the response surfacemethodology (RSM), using heat and ultrasound assisted extraction techniques(HAE and UAE). The obtained results were compared with that of thestandard Soxhlet procedure. RSM was applied using a circumscribed centralcomposite design with three variables (time, ethanol content, and temperatureor ultrasonic power) and five levels. The conditions that maximize theresponses (extraction yield, triterpenoids and total phenolics) were: 78.9 min,90.0 °C and 62.5% ethanol and 40 min, 100.0 W and 89.5% ethanol for HAEand UAE, respectively. However, the cited document discloses extractionthrough response surface methodology, which does not provide accurateoptimization results due to multiple responses at a time. Moreover, theoptimization results obtained through response surface methodology arelimited to a specific scale.Alyona A. Petrochenko et al., Received: 4 March 2023 Accepted: 13 April2023 Published: 21 April 2023, Molecules 2023, 28, 3614.https: / / doi.org / 10.3390 / molecules28083614 discloses the roots of themedicinal plant Aralia elata that are rich in biologically active naturalproducts, with triterpene saponins constituting one of their major groups. Dueto their low toxicity, natural deep eutectic solvents (NADES) were recentlyproposed as a promising alternative extractant for the isolation of naturalproducts from medicinal plants. Therefore, the potential of NADES in theextraction of triterpene saponins from the roots of A. elata is addressed.Triterpene saponins were successfully extracted from all tested NADES, withthe highest efficiency achieved using a 1:1 mixture of choline chloride andmalic acid, as well as a 1:3 mixture of choline chloride and lactic acid.However, the cited document discloses an extraction process by using aplurality of metabolites that makes the extraction method expensive and atime-consuming process.In view of the above, the aforementioned extraction processes of the state ofthe art that are widely used for the management of cancer possess somesignificant drawbacks. The afore-mentioned documents involve complexmethodology and utilize expensive constituents, that makes the extraction atime-consuming process. Moreover, the methodology involves complextechniques, which alters the optimization results and makes the extraction acumbersome process. Additionally, few chemical agents employed in theprocesses are toxic, non-biodegradable and bio-accumulative in nature therebyposing ecological risks.Therefore, there is a need to develop a sustainable method for extraction oftriterpenoids, which is cost-effective and environment-friendly with maximumyield, thereby making the process more accessible and sustainable.OBJECT OF THE INVENTIONThe main object of the present invention is to provide a process for extractionof a cycloartane triterpenoid.Another object of the present invention is to provide a process for extractionof a pharmacologically active compound, beddomeilactone from the bark ofDysoxylum malabaricum through a solvent extraction method.Another object of the present invention is to provide a process for extractionof a cycloartane triterpenoid that exhibits cytotoxicity against different breastcancer cells thereby providing effective management of the breast cancer.Yet another object of the present invention is to provide a process forextraction of a cycloartane triterpenoid with 80% purity from plant bark.Still another object of the present invention is to provide a process ofextraction that is cost-effective and environment-friendly.SUMMARY OF THE INVENTIONThe present invention relates to a process for extraction of a cycloartanetriterpenoid from the bark of Dysoxylum malabaricum to isolate apharmacologically active compound, beddomeilactone that exhibitscytotoxicity against different breast cancer cells for effective management ofbreast cancer.In an embodiment, the present invention provides a process for extraction of acycloartane triterpenoid comprising the steps of: a) collecting and grinding aplurality of dried barks of a herbal plant to coarse size to form a powder; b)mixing said powder obtained in step (a) with a first extraction solvent in apredefined ratio to form a crude extract A; c) mixing said powder obtained instep (a) with a second extraction solvent in a predefined ratio to form a crudeextract B; d) subjecting said crude extract A obtained in step (b) and saidcrude extract B obtained in step (c) to filtration through a vacuum filter toform a filtrate A and a filtrate B; e) adding deionized water to said filtrate Bobtained in step (d) in a ratio of 1:10 to form a solution of filtrate B; f)subjecting said solution of filtrate B obtained in step (e) to ultrasonication for20 minutes at a temperature ranging from 308 to 313 K to form anultrasonicated filtrate B; g) concentrating said ultrasonicated filtrate Bobtained in step (f) through a vacuum rotary evaporator to obtain a residue ofsaid ultrasonicated filtrate B; and h) filtering said residue of saidultrasonicated filtrate B obtained in step (g) through a glass filter with the aidof a celite filter to extract said cycloartane triterpenoid; wherein, saidcycloartane triterpenoid is beddomeilactone; said predefined ratio in step (b)of said powder and first extraction solvent is 1:12 solid-to-solvent ratio; saidpredefined ratio in step (c) of said powder and second extract solvent is 1:12solid-to-solvent ratio; said first extraction solvent is ethanol; and said secondextraction solvent is natural deep eutectic solvent (NADES) that is acombination of acetic acid, mannitol and hexanoic acid.The present invention relates to a process for extraction of a cycloartanetriterpenoid, preferably beddomeilactone from the bark of Dysoxylummalabaricum through a solvent extraction method for effective management ofbreast cancer.The above objects and advantages of the present invention will becomeapparent from the hereinafter set forth brief description of the drawings,detailed description of the invention, and claims appended herewith.BRIEF DESCRIPTION OF THE DRAWINGSAn understanding of a process for extraction of a cycloartane triterpenoid ofthe present invention may be obtained by reference to the following drawings:Figure 1 is a schematic representation of step-by-step synthesis process forextraction of a cycloartane triterpenoid, according to an embodiment of thepresent invention.Figure 2 is a graphical representation of high-performance liquidchromatography (HPLC) chromatogram of crude extract, according to thepresent invention.Figure 3 is a graphical representation of high-performance liquidchromatography (HPLC) chromatogram of beddomeilactone using analyticalcolumn, according to the present invention.Figure 4 is a graphical representation of proton nuclear magnetic resonance(NMR) of beddomeilactone, according to the present invention.Figure 5 is a graphical representation of carbon-13 nuclear magneticresonance (13C NMR) of beddomeilactone, according to the presentinvention.Figure 6 is a graphical representation of Mass spectra of beddomeilactone,according to the present invention.DETAILED DESCRIPTION OF THE INVENTIONThe present invention will now be described hereinafter with reference to theaccompanying drawings in which a preferred embodiment of the invention isshown. This invention may, however, be embodied in many different formsand should not be construed as being limited to the embodiment set forthherein. Rather, the embodiment is provided so that this disclosure will bethorough, and will fully convey the scope of the invention to those skilled inthe art.The present invention now will be described hereinafter with reference to thedetailed description, in which some, but not all embodiments of the inventionare indicated. Indeed, the invention may be embodied in many different formsand should not be construed as limited to the embodiments set forth herein;rather, these embodiments are provided so that this disclosure will satisfyapplicable legal requirements. Like numbers refer to like elements throughout.The present invention is described fully herein with non-limiting embodimentsand exemplary experimentation.The present invention relates to a process for extraction of a cycloartanetriterpenoid from natural deep eutectic solvents (NADES) to isolate apharmacologically active compound, beddomeilactone from bark ofDysoxylum malabaricum that exhibits cytotoxicity against different breastcancer cells for effective management of breast cancer.In a preferred embodiment, a process for extraction of a cycloartanetriterpenoid comprises of the following steps: (a) collecting and grinding aplurality of dried barks of a herbal plant to coarse size to obtain a powder; b)mixing the powder as obtained in step (a) with a first extraction solvent in apredefined ratio to obtain a crude extract A; c) mixing the powder as obtainedin step (a) with a second extraction solvent in a predefined ratio to obtain acrude extract B; d) subjecting the crude extract A and the crude extract B asobtained in step (b) and step (c) through a vacuum filter to obtain a filtrate Aand filtrate B; d) adding deionized water to said filtrate B as obtained in step(d) in a ratio ranging from 1:10 to obtain a solution of filtrate B; e) addingdeionized water to the filtrate B as obtained in step (e) to ultrasonication for20 min at a temperature ranging from 308 to 313 K to obtain anultrasonicated filtrate B; g) concentrating the ultrasonicated filtrate B asobtained in step (f) through a vacuum rotary evaporator to obtain a residue ofthe ultrasonicated filtrate B; and h) filtering the residue of the ultrasonicatedfiltrate B as obtained in step (g) through a glass filter with the aid of celite filterto extract a cycloartane triterpenoid; wherein the cycloartane triterpenoid is abeddomeilactone; the predefined ratio in step (b) and step (c) of the powderand extraction solvent A and B is 1:12 solid-to-solvent ratio, the firstextraction solvent is ethanol and the second extraction solvent is a naturaldeep eutectic solvent (NADES) that is a combination of acetic acid, mannitoland hexanoic acid.Herein, the herbal plant is Dysoxylum malabaricum. The filtrate A is ethanolicextract. The filtrate B is an extract of natural deep eutectic solvent (NADES).The solution of filtrate B in step (f) is subjected to ultrasonication at anultrasonic frequency of 40 kHz and a power output of 300 W. The crudeextracts A and B as obtained in step (b) and step (c) are filtered through Grade1 MN615A filter paper to obtain the filtrate A and filtrate B. The cycloartanetriterpenoids exhibit cytotoxicity against breast cancer cells which includesMCF-7 (breast carcinoma), A549 (lung epithelial carcinoma), MDM231(breast adenocarcinoma), Hs578t (breast carcinoma), ZR-75-30, FaDUhuman pharynx squamous cell carcinoma, BT549. Further, the cycloartanetriterpenoid is extracted with a yield of 5 -7 gm. The process extracts 1% of thebeddomeilactonewith 80% purity from plant bark, the cycloartane triterpenoidis extracted via solvent extraction method.Referring to Figure 1, a schematic representation of step-by-step synthesisprocess for extraction of a cycloartane triterpenoid has been illustrated.EXAMPLE 1For Experimentation DetailsMaterials and MethodExtraction processThe process for extraction of a cycloartane triterpenoid for isolation ofbeddomeilacton was done from natural deep eutectic solvent (NADES) andionic liquid. Firstly, the plurality of dried barks were collected and groundedmechanically to coarse size and then powder of D. malabaricum (that wasprocured from SM Sehgal Foundation Centre for Biodiversity andConservation, Plot No. 34, Institutional Area, Sector 44, Gurugram, Haryana122003) were mixed with the extraction solvents such as natural deep eutecticsolvents (NADES). Consequently, solvent extraction was done using ethanoland NADES, where ethanol and NADES (mixture of acetic acid, mannitol,and hexanoic acid) were selected to obtain a crude extract A, preferablyethanolic extract and a crude extract B, preferably extract of natural deepeutectic solvents (NADES). The solvent extraction was done at 308 K for 30min following a 1:12 solid-to-solvent ratio. After extraction, the ethanolicextract and extract of NADES were filtered using a vacuum filter with thehelp of Grade 1 MN615A filter paper to obtain filtrate of ethanolic extract andfiltrate of extract of NADES. The ethanolic extract and extract of NADESwere stirred separately at room temperature for 30 min for proper mixingwithin the solvents in each extract. The filtrate of ethanolic extract obtainedpost-extraction was concentrated using a vacuum rotary evaporator. Further,to isolate the phytochemicals from the filtrate of NADES extract, deionizedwater was added to the extract of NADES separately in the ratio of 1:10 v / v(NADES: deionized water). The resulting mixture was subjected toultrasonication for 20 min at 308 K at an ultrasonic frequency of 40 kHz and apower output of 300 W to obtain an ultrasonicated filtrate of extract ofNADES. The ultrasonicated filtrate of extract of NADES was furtherconcentrated using the vacuum rotary evaporator to obtain a residue of thefiltrate of extract of NADES. Further, the residue of the filtrate of extract ofNADES was filtered through a glass filter with the aid of celite filter, and thepresence of triterpenoids was detected via Liquid Chromatography-HighResolution Mass Spectrometry (LC-HRMS) and the Proton nuclear magneticresonance (HNMR). The cycloartane triterpenoid enriched fraction wasstandardized by high-performance liquid chromatography (HPLC) using thestandard biomarker that resulted in the rapid isolation of purebeddomeilactone using semi-preparative and analytical HPLC.EXAMPLE 2CharacterizationSelection of solvent from the extract of herbal plants is guided by severalfactors such as cost-effectiveness, low adverse impact, and selective extractionof the specific active phytoconstituents. Natural deep eutectic solvents(NADES) are a class of green and customizable solvents and are increasinglyused for phytochemical extraction. The present invention relates to the bulkextraction and isolation of bioactive cycloartane triterpenoids from the bark ofDysoxylum malabaricum using ionic liquids. This eco-friendly process enablesthe selective extraction of the pharmacologically important compound,beddomeilactone that is a key cycloartane triterpenoid and has demonstratednotable biological activity.In the present invention, the chromatogram of the crude extract of NADESand single-isolated phytoconstituent, that is beddomeilactone are compared,as shown in Figure 2 and Figure 3. At a retention time of range of 10.5 to12.0 min, a peak of high-intensity was observed, which was targeted forisolation. Further, a good yield of the targeted pure compound was obtainedvia analytical HPLC column chromatography.Further, to confirm the structure of isolated compound beddomeilactone,extensive spectral analysis were carried out for the isolated compound. Thespectral analysis included techniques like NMR, HR-ESIMS, and LC-MSexperiments, as shown in Figure 4, Figure 5, and Figure 6. The spectral dataconcluded that the targeted compound structure was cycloartane triterpenoidfused ring system and the compound was identified as beddomeilactone.The results demonstrated that the process at varying concentrations andratios, under different temperature conditions, produced three to six timesmore beddomeilactone compared to conventional extraction methodsinvolving water, ethanol, and methanol alone and their combinations, with orwithout heating.In the present invention, the natural deep eutectic solvents (NADES) are usedfor the identification of phytoconstituents by applying the solvent extractionmethod. NADES exhibits higher extraction efficiency for a wide range ofbioactive compounds compared to conventional solvents. NADES extractsboth polar and non-polar compounds due to their tunable properties. Solventextraction was done using natural deep eutectic solvents where ethanol,NADES (mixture of acetic acid, mannitol, and hexanoic acid) effectivelydetected the cycloartane triterpenoids in the ionic liquid fraction of barkextract. Further, the targeted compounds were subjected to isolation and thestudy resulted in the isolation of beddomeilactone and cycloartanetriterpenoids. Additionally, beddomeilactone exhibited notable cytotoxicityagainst different breast cancer cells which includes MCF-7 (breast carcinoma),A549 (lung epithelial carcinoma), MDM-231(breast adenocarcinoma), Hs578t(breast carcinoma), ZR-75-30, FaDU human pharynx squamous cellcarcinoma, BT549.Therefore, the present invention provides a cost-effective, eco-friendly processfor extraction of cycloartane triterpenoid, preferably beddomeilactone fromthe bark of Dysoxylum malabaricum for effective management of breast cancerby exhibiting cytotoxicity against different breast cancer cells. The aforementioned eco-friendly process enables selective extraction of thepharmacologically active compound, beddomeilactone.Many modifications and other embodiments of the invention set forth hereinwill readily occur to one skilled in the art to which the invention pertainhaving the benefit of the teachings presented in the foregoing descriptions andthe associated drawings. Therefore, it is to be understood that the invention isnot to be limited to the specific embodiments disclosed and that modificationsand other embodiments are intended to be included within the scope of theappended claims. Although specific terms are employed herein, they are usedin a generic and descriptive sense only and not for purposes of limitation.
Claims
1. A process for the extraction of a cycloartane triterpenoid comprising the steps of: a) collecting and grinding a plurality of dried barks of a herbal plant to a coarse size to form a powder; b) mixing said powder obtained in step (a) with a first extraction solvent in a predefined ratio to form a crude extract A; c) mixing said powder obtained in step (a) with a second extraction solvent in a predefined ratio to form a crude extract B; d) subjecting said crude extract A obtained in step (b) and said crude extract B obtained in step (c) to filtration through a vacuum filter to form a filtrate A and a filtrate B; e) adding deionized water to said filtrate B obtained in step (d) in a ratio of 1:10 to form a solution of filtrate B; f) subjecting said solution of filtrate B obtained in step (e) to ultrasonication for 20 minutes at a temperature ranging from 308 to 313 K to form an ultrasonicated filtrate B; g) concentrating said ultrasonicated filtrate B obtained in step (f) through a vacuum rotary evaporator to form a residue of said ultrasonicated filtrate B; and h) filtering said residue of said ultrasonicated filtrate B obtained in step (g) through a glass filter to obtain said cycloartane triterpenoid; wherein, said cycloartane triterpenoid is beddomeilactone; said predefined ratio in step (b) of said powder and first extraction solvent is 1:12 solid-to-solvent ratio; said predefined ratio in step (c) of said powder and second extraction solvent is 1:12 solid-to-solvent ratio; said first extraction solvent is ethanol; and said second extraction solvent is natural deep eutectic solvent (NADES) that is a combination of acetic acid, mannitol and hexanoic acid.
2. The process as claimed in claim 1, wherein said herbal plant is Dysoxylum malabaricum.
3. The process as claimed in claim 1, wherein said filtrate A is ethanolic extract.
4. The process as claimed in claim 1, wherein said filtrate B is an extract of said natural deep eutectic solvent (NADES).
5. The process as claimed in claim 1, wherein said solution of filtrate B in step (f) is subjected to ultrasonication at an ultrasonic frequency of 40 kHz and a power output of 300 W.
6. The process as claimed in claim 1, wherein said crude extract A and said crude extract B obtained in step (b) and step (c) are filtered through Grade 1 MN615A filter paper to obtain said filtrate A and said filtrate B.
7. The process as claimed in claim 1, wherein said cycloartane triterpenoid exhibit cytotoxicity against breast cancer cells including MCF-7 (breast carcinoma), A549 (lung epithelial carcinoma), MDM- 231(breast adenocarcinoma), Hs578t (breast carcinoma), ZR-75-30, FaDU human pharynx squamous cell carcinoma and BT549 (breast carcinoma).
8. The process as claimed in claim 1, wherein said cycloartane triterpenoid is extracted with a yield of 5 - 7 gm.
9. The process as claimed in claim 1, wherein said process extracts 1% of beddomeilactone with 80% purity from said plurality of dried barks.10.The process as claimed in claim 1, wherein said cycloartane triterpenoid is extracted through solvent extraction method.
